1. Home
  2. BIO vs CELH Comparison

BIO vs CELH Comparison

Compare BIO & CELH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIO
  • CELH
  • Stock Information
  • Founded
  • BIO 1952
  • CELH 2004
  • Country
  • BIO United States
  • CELH United States
  • Employees
  • BIO N/A
  • CELH N/A
  • Industry
  • BIO Biotechnology: Laboratory Analytical Instruments
  • CELH Beverages (Production/Distribution)
  • Sector
  • BIO Industrials
  • CELH Consumer Staples
  • Exchange
  • BIO Nasdaq
  • CELH Nasdaq
  • Market Cap
  • BIO 9.2B
  • CELH 7.5B
  • IPO Year
  • BIO N/A
  • CELH N/A
  • Fundamental
  • Price
  • BIO $245.57
  • CELH $36.75
  • Analyst Decision
  • BIO Strong Buy
  • CELH Buy
  • Analyst Count
  • BIO 4
  • CELH 17
  • Target Price
  • BIO $415.25
  • CELH $45.53
  • AVG Volume (30 Days)
  • BIO 397.4K
  • CELH 9.1M
  • Earning Date
  • BIO 05-06-2025
  • CELH 05-06-2025
  • Dividend Yield
  • BIO N/A
  • CELH N/A
  • EPS Growth
  • BIO N/A
  • CELH N/A
  • EPS
  • BIO N/A
  • CELH 0.45
  • Revenue
  • BIO $2,566,500,000.00
  • CELH $1,355,630,000.00
  • Revenue This Year
  • BIO $1.11
  • CELH $34.11
  • Revenue Next Year
  • BIO $4.55
  • CELH $17.00
  • P/E Ratio
  • BIO N/A
  • CELH $81.08
  • Revenue Growth
  • BIO N/A
  • CELH 2.85
  • 52 Week Low
  • BIO $235.84
  • CELH $21.10
  • 52 Week High
  • BIO $387.99
  • CELH $98.85
  • Technical
  • Relative Strength Index (RSI)
  • BIO 36.97
  • CELH 71.21
  • Support Level
  • BIO $235.84
  • CELH $33.19
  • Resistance Level
  • BIO $249.37
  • CELH $32.08
  • Average True Range (ATR)
  • BIO 7.74
  • CELH 1.89
  • MACD
  • BIO 1.47
  • CELH 0.41
  • Stochastic Oscillator
  • BIO 39.59
  • CELH 93.10

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About CELH Celsius Holdings Inc.

Celsius Holdings plays in the energy drink subsegment of the global nonalcoholic beverage market, with 96% of revenue concentrated in North America. Celsius' products contain natural ingredients and a metabolism-enhancing formulation, appealing to fitness and active lifestyle enthusiasts. The firm's portfolio includes its namesake Celsius Originals beverages, Celsius Essentials line (containing aminos), and Celsius On-the-Go powder packets. Celsius dedicates its efforts to branding and innovation, while it utilizes third parties for the manufacturing, packaging, and distribution of its products. In 2022, Celsius forged a 20-year distribution agreement with PepsiCo, which holds an 8.5% stake in the business.

Share on Social Networks: